12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga · 04/30 12:07
Gainers
- Regulus Therapeutics (NASDAQ:RGLS) shares increased by 134.1% to $7.89 during Wednesday's pre-market session. The company's market cap stands at $522.6 million.
- INVO Fertility (NASDAQ:IVF) shares rose 39.75% to $2.25. The company's market cap stands at $11.1 million.
- Sera Prognostics (NASDAQ:SERA) stock increased by 24.16% to $3.7. The company's market cap stands at $139.3 million.
- LogicMark (NASDAQ:LGMK) shares increased by 21.47% to $0.02.
- GlucoTrack (NASDAQ:GCTK) stock increased by 18.72% to $0.2. The market value of their outstanding shares is at $5.2 million.
- Performant Healthcare (NASDAQ:PHLT) shares moved upwards by 17.44% to $2.76. The company's market cap stands at $216.1 million.
Losers
- InnovAge Holding (NASDAQ:INNV) stock declined by 37.4% to $1.91 during Wednesday's pre-market session. The company's market cap stands at $258.3 million.
- GeneDx Holdings (NASDAQ:WGS) shares decreased by 28.19% to $84.0. The market value of their outstanding shares is at $2.3 billion. The company's, Q1 earnings came out today.
- Immunic (NASDAQ:IMUX) shares decreased by 21.88% to $1.0. The company's market cap stands at $95.8 million.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock fell 18.21% to $0.25. The market value of their outstanding shares is at $3.4 million.
- NeOnc Technologies (NASDAQ:NTHI) stock declined by 13.03% to $5.21. The company's market cap stands at $117.5 million.
- Arvinas (NASDAQ:ARVN) shares decreased by 12.35% to $8.21. The market value of their outstanding shares is at $564.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.